Leadership
At Voiant, our Leadership Team comprises seasoned experts from diverse domains of medical, scientific, and clinical research.
Backed by a distinguished Board of Directors with deep-rooted experience in healthcare, our leaders steer Voiant with a commitment to innovation, quality, and excellence. This dynamic team synergizes to navigate Voiant on its mission of revolutionizing clinical trial imaging with an unwavering focus on quality and groundbreaking advancements.
Meet our team
Ophthalmology Subject Matter Experts
Minzhong Yu, PhD, MMed
ERG
Vlad Diaconita, MD, FRCS(C)
AI/ML
Weijie Violet Lin, MD, ABO
Cornea
Ives “Tony” Valenzuela, MD
Glaucoma
Ophthalmology Scientific Advisory Board
Dr. David Boyer
Retina-Vitreous Associates Medical Group
Dr. David Brown
Retina Consultants of Texas
Dr. Robyn Guymer
Centre for Eye Research Australia
Dr. Tim Jackson
The King’s College Hospital London
Dr. Arshad Khanani
Sierra Eye Associates
Dr. Anat Loewenstein
Tel Aviv Medical Center
Dr. Eric Souied
Créteil Intercommunal Hospital Henri-Mondor
Dr. Charles Wykoff
Retina Consultants of Texas
Jeff Kinell
Chairman, Operating Partner DFW Capital Partners
Jim Primerano
CEO
Brett Prager
Director, General Partner
DFW Capital Partners
Andrew White
Principal
DFW Capital Partners
Jonathan Goldin, MD, PhD
Scientific Advisory
Matt Brown, PhD
Scientific Advisory
Lori Wright
Director, Operating Partner, DFW Capital Partners
Connect with us
The future of clinical trial imaging has arrived. Let’s talk about what your next trial needs to succeed.


















